Kezar Life Sciences (NASDAQ:KZR) Given “Outperform” Rating at William Blair
William Blair restated their outperform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research report released on Friday, Marketbeat Ratings reports. Several other research firms have also recently issued reports on KZR. Wells Fargo & Company lowered their price objective on Kezar Life Sciences from $11.00 to $9.00 and set […]
William Blair restated their outperform rating on shares of Kezar Life Sciences (NASDAQ:KZR – Free Report) in a research report released on Friday, Marketbeat Ratings reports. Several other research firms have also recently issued reports on KZR. Wells Fargo & Company lowered their price objective on Kezar Life Sciences from $11.00 to $9.00 and set […]
